Kristin Roshelli is a partner in King & Spalding’s Houston Healthcare practice. Kristin’s practice focuses exclusively in the healthcare and life sciences industries.  She represents healthcare investors and a broad range of prominent healthcare clients including health systems, hospitals, academic medical centers, medical schools, physician groups, ambulatory surgical centers, and clinical laboratories. She also advises leading pharmaceutical companies in complex collaboration arrangements with third parties and in establishing their pharmaceutical supply chain contracts.  

Kristin regularly assists clients with mergers and acquisitions, affiliations, general health law questions, and complex corporate governance matters.  Kristin advises clients on defending government investigations relating to Medicare and Medicaid billing, appealing alleged overpayments, self-disclosing potential overpayments, and analyzing arrangements under state and federal fraud and abuse authorities, including the Stark physician self-referral and anti-kickback statutes. 

She is Chambers-ranked for healthcare in Texas and has been recognized by Legal 500 as a “Recommended Key Lawyer,” by Texas Super Lawyers as a healthcare rising star, and by Texas Lawyers with an “On the Rise Award,” which recognizes lawyers under the age of 40 who have wielded influence in their practice areas in Texas and beyond.  Prior to entering the legal field, Kristin served as a nurse in the United States Air Force, worked in the general counsel’s office of a large academic medical center, and practiced as a registered nurse in a medical intensive care unit. 

Publications

• 2016 Health Care Fraud and Abuse Top Ten List Reimbursement Advisor, Vol 32, No. 6, February 2017
• “The Plot Thickens for the Medicare Narrative Requirement,” Law360, February 2015
• “When is a Hospital a ‘New Hospital?,’” Reimbursement Advisor, Vol. 30, No. 4, December 2014

Back to Page